Skip to content

Clitoral Location in Relation to Sexual Function Using Pelvic Imaging

Clitoral Location in Relation to Sexual Function Using Pelvic MRI: A Case-Control Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01195701
Enrollment
35
Registered
2010-09-06
Start date
2010-07-31
Completion date
2012-09-30
Last updated
2014-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorgasmia, Female Sexual Dysfunction

Keywords

female sexual dysfunction, anorgasmia, clitoral complex, pelvic MRI, testosterone

Brief summary

Women who are unable to achieve orgasm compared to women who have normal orgasmic function may have different clitoral anatomy and different hormone levels. The investigators hypothesis is that women who have difficulty with orgasm may have a clitoris that is closer to the vagina and may have higher testosterone levels. Pelvic MRI will be used to observe whether clitoral measurements differ between women with normal orgasmic function vs. those with anorgasmia.

Detailed description

Women unable with anorgasmia and those with normal orgasmic function will undergo pelvic MRI so that clitoral measurements can be taken and then compared for differences.

Interventions

None listed

Sponsors

TriHealth Hatton Research Institute
CollaboratorOTHER
TriHealth Inc.
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Premenopausal female aged 18-55 years * Sexually active (at least 1 heterosexual partner in the past 4 weeks) * Cases must have difficulty with orgasm or be anorgasmic * Controls must have normal sexual function

Exclusion criteria

* Not sexually active * Homosexual orientation * Postmenopausal * Stage \>2 pelvic organ prolapse (POP-Q measurements beyond hymen) * Urinary incontinence with coitus limiting sexual activity * Severe vaginal atrophy * Pelvic pain/dyspareunia ( * Currently pregnant * Depression being treated with SSRIs (depression alone or treatment of depression with non-SSRI medications is not an exclusion) * Currently taking testosterone supplements * History of sexual abuse * Large pelvic mass (benign or cancerous) impeding MRI measurements or grossly abnormal pelvic anatomy.

Design outcomes

Primary

MeasureTime frameDescription
Clitoral Measurements Using Pelvic MRIBetween day 1-14 (follicular phase) of menstrual cycleAll cases and controls will undergo a pelvic MRI without contrast to assess the clitoral complex.

Secondary

MeasureTime frameDescription
Total TestosteroneBetween day 1-14 (follicular phase) of menstrual cycleFree & total testosterone, and the calculated free androgen index will be compared; additionally, these levels will be correlated with the questionnaire data and clitoral measurements
Free Androgen IndexBetween day 1-14 (follicular phase) of menstrual cycleFree androgen index is calculated as the ratio of total testosterone to sex hormone binding globulin (SHBG)
Female Sexual Function Index (FSFI) Total Scorebaseline visitThe FSFI is a validated index of sexual function, consisting of a total score and six subscales or domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. The FSFI total is the sum of the six domain scores, each of which is weighted as noted. The FSFI total score can range from 2 to 36, with higher scores indicating better sexual function. A total score of 26.55 has been identified as the ideal cut point for differentiating between normal sexual function and sexual dysfunction.
FSFI Desirebaseline visitThe desire domain of the Female Sexual Function Index (FSFI) consists of two questions and measures the frequency (almost never to almost always) and level (very low to very high) of sexual desire. Item scores range from 1 to 5, with higher scores indicating better sexual function, and the domain score is weighted by a factor of 0.6, such that the domain score can range from 1.2 to 6.0.
Free TestosteroneBetween day 1-14 (follicular phase) of menstrual cycleFree testosterone and the calculated free androgen index will be compared; additionally, these levels will be correlated with the questionnaire data and clitoral measurements
FSFI Lubricationbaseline visitThe lubrication domain of the Female Sexual Function Index (FSFI) consists of four questions and measures the frequency of lubrication (almost never to almost always), the difficulty in becoming lubricated (extremely difficult to not difficult), frequency of maintaining lubrication (almost never to almost always), and difficulty in maintaining lubrication (extremely difficult to not difficult). Item scores range from 0 to 5, with higher scores indicating better sexual function, and the lubrication score is weighted by a factor of 0.3, such that the domain score can range from 0 to 6.0.
FSFI Orgasmbaseline visitThe orgasm domain of the Female Sexual Function Index (FSFI) consists of three questions and measures the frequency of orgasm (almost never to almost always), difficulty in achieving orgasm (extremely difficult to not difficult), and satisfaction with the ability to reach orgasm (very dissatisfied to very satisfied). Item scores range from 0 to 5, with higher scores indicating better sexual function, and the orgasm score is weighted by a factor of 0.4, such that the domain score can range from 0 to 6.0.
FSFI Satisfactionbaseline visitThe satisfaction domain of the Female Sexual Function Index (FSFI) consists of three questions and measures satisfaction (very dissatisfied to very satisfied) with emotional closeness with partner, sexual relationship with partner, and overall sexual relationship with partner. Item scores range from 0 (or 1) to 5, with higher scores indicating better sexual function, and the satisfaction score is weighted by a factor of 0.4, such that the domain score can range from 0.8 to 6.0.
FSFI Painbaseline visitThe pain domain of the Female Sexual Function Index (FSFI) consists of three questions and measures the frequency of discomfort or pain during and following vaginal penetration (almost never to almost always), and the level of discomfort or pain (very low to very high). Item scores range from 0 to 5, with higher scores indicating better sexual function, and the pain score is weighted by a factor of 0.4, such that the domain score can range from 0 to 6.0.
FSFI Arousalbaseline visitThe arousal domain of the Female Sexual Function Index (FSFI) consists of four questions and measures the frequency (almost never to almost always) and level (very low to very high) of sexual arousal; and confidence in becoming aroused (very low to very high confidence) and frequency of satisfaction with arousal (almost never to almost always). Item scores range from 0 to 5, with higher scores indicating better sexual function, and the arousal score is weighted by a factor of 0.3, such that the domain score can range from 0 to 6.0.

Countries

United States

Participant flow

Participants by arm

ArmCount
Anorgasmia (Cases)
Women with difficulty or inability to reach sexual climax will be the cases in this study.
10
Normal Orgasmic Function
Women who report that they usually or always achieve sexual climax will be the controls in this study.
20
Total30

Baseline characteristics

CharacteristicNormal Orgasmic FunctionTotalAnorgasmia (Cases)
Age, Continuous31.6 years
STANDARD_DEVIATION 7.2
31.6 years
STANDARD_DEVIATION 7.4
31.7 years
STANDARD_DEVIATION 8.2
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Black or African American
0 Participants1 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
19 Participants27 Participants8 Participants
Sex: Female, Male
Female
20 Participants30 Participants10 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 100 / 20
serious
Total, serious adverse events
0 / 100 / 20

Outcome results

Primary

Clitoral Measurements Using Pelvic MRI

All cases and controls will undergo a pelvic MRI without contrast to assess the clitoral complex.

Time frame: Between day 1-14 (follicular phase) of menstrual cycle

ArmMeasureGroupValue (MEAN)Dispersion
Anorgasmia (Cases)Clitoral Measurements Using Pelvic MRIBody distance, sagittal, mm29.4 millimeters (mm)Standard Deviation 6.8
Anorgasmia (Cases)Clitoral Measurements Using Pelvic MRICrura distance, lateral axial, mm15.6 millimeters (mm)Standard Deviation 6.1
Anorgasmia (Cases)Clitoral Measurements Using Pelvic MRIGlans distance, sagittal, mm51.3 millimeters (mm)Standard Deviation 7.6
Anorgasmia (Cases)Clitoral Measurements Using Pelvic MRITotal vaginal length, mm84.5 millimeters (mm)Standard Deviation 11.1
Anorgasmia (Cases)Clitoral Measurements Using Pelvic MRICrura distance, medial axial, mm24.2 millimeters (mm)Standard Deviation 5.2
Anorgasmia (Cases)Clitoral Measurements Using Pelvic MRIClitoris to skin distance, mm26.6 millimeters (mm)Standard Deviation 11.4
Anorgasmia (Cases)Clitoral Measurements Using Pelvic MRIMidurethra-midvagina distance, mm13.3 millimeters (mm)Standard Deviation 2.5
Normal Orgasmic FunctionClitoral Measurements Using Pelvic MRIClitoris to skin distance, mm27.0 millimeters (mm)Standard Deviation 6.2
Normal Orgasmic FunctionClitoral Measurements Using Pelvic MRIMidurethra-midvagina distance, mm12.6 millimeters (mm)Standard Deviation 1
Normal Orgasmic FunctionClitoral Measurements Using Pelvic MRIGlans distance, sagittal, mm45.1 millimeters (mm)Standard Deviation 5.7
Normal Orgasmic FunctionClitoral Measurements Using Pelvic MRIBody distance, sagittal, mm20.6 millimeters (mm)Standard Deviation 3.2
Normal Orgasmic FunctionClitoral Measurements Using Pelvic MRICrura distance, medial axial, mm28.3 millimeters (mm)Standard Deviation 4.6
Normal Orgasmic FunctionClitoral Measurements Using Pelvic MRICrura distance, lateral axial, mm23.8 millimeters (mm)Standard Deviation 3.7
Normal Orgasmic FunctionClitoral Measurements Using Pelvic MRITotal vaginal length, mm94.9 millimeters (mm)Standard Deviation 6.5
Secondary

Female Sexual Function Index (FSFI) Total Score

The FSFI is a validated index of sexual function, consisting of a total score and six subscales or domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. The FSFI total is the sum of the six domain scores, each of which is weighted as noted. The FSFI total score can range from 2 to 36, with higher scores indicating better sexual function. A total score of 26.55 has been identified as the ideal cut point for differentiating between normal sexual function and sexual dysfunction.

Time frame: baseline visit

ArmMeasureValue (MEAN)Dispersion
Anorgasmia (Cases)Female Sexual Function Index (FSFI) Total Score20.2 units on a scaleStandard Deviation 4.4
Normal Orgasmic FunctionFemale Sexual Function Index (FSFI) Total Score31.6 units on a scaleStandard Deviation 2.7
Secondary

Free Androgen Index

Free androgen index is calculated as the ratio of total testosterone to sex hormone binding globulin (SHBG)

Time frame: Between day 1-14 (follicular phase) of menstrual cycle

ArmMeasureValue (NUMBER)
Anorgasmia (Cases)Free Androgen Index1.3 ratio
Normal Orgasmic FunctionFree Androgen Index1.2 ratio
Secondary

Free Testosterone

Free testosterone and the calculated free androgen index will be compared; additionally, these levels will be correlated with the questionnaire data and clitoral measurements

Time frame: Between day 1-14 (follicular phase) of menstrual cycle

ArmMeasureValue (MEDIAN)
Anorgasmia (Cases)Free Testosterone2.6 pg/mL
Normal Orgasmic FunctionFree Testosterone2.5 pg/mL
Secondary

FSFI Arousal

The arousal domain of the Female Sexual Function Index (FSFI) consists of four questions and measures the frequency (almost never to almost always) and level (very low to very high) of sexual arousal; and confidence in becoming aroused (very low to very high confidence) and frequency of satisfaction with arousal (almost never to almost always). Item scores range from 0 to 5, with higher scores indicating better sexual function, and the arousal score is weighted by a factor of 0.3, such that the domain score can range from 0 to 6.0.

Time frame: baseline visit

ArmMeasureValue (MEAN)Dispersion
Anorgasmia (Cases)FSFI Arousal3.2 units on a scaleStandard Deviation 0.7
Normal Orgasmic FunctionFSFI Arousal5.4 units on a scaleStandard Deviation 0.6
Secondary

FSFI Desire

The desire domain of the Female Sexual Function Index (FSFI) consists of two questions and measures the frequency (almost never to almost always) and level (very low to very high) of sexual desire. Item scores range from 1 to 5, with higher scores indicating better sexual function, and the domain score is weighted by a factor of 0.6, such that the domain score can range from 1.2 to 6.0.

Time frame: baseline visit

ArmMeasureValue (MEAN)Dispersion
Anorgasmia (Cases)FSFI Desire2.6 units on a scaleStandard Deviation 1.4
Normal Orgasmic FunctionFSFI Desire4.8 units on a scaleStandard Deviation 0.7
Secondary

FSFI Lubrication

The lubrication domain of the Female Sexual Function Index (FSFI) consists of four questions and measures the frequency of lubrication (almost never to almost always), the difficulty in becoming lubricated (extremely difficult to not difficult), frequency of maintaining lubrication (almost never to almost always), and difficulty in maintaining lubrication (extremely difficult to not difficult). Item scores range from 0 to 5, with higher scores indicating better sexual function, and the lubrication score is weighted by a factor of 0.3, such that the domain score can range from 0 to 6.0.

Time frame: baseline visit

ArmMeasureValue (MEAN)Dispersion
Anorgasmia (Cases)FSFI Lubrication4.0 units on a scaleStandard Deviation 1.3
Normal Orgasmic FunctionFSFI Lubrication5.5 units on a scaleStandard Deviation 0.5
Secondary

FSFI Orgasm

The orgasm domain of the Female Sexual Function Index (FSFI) consists of three questions and measures the frequency of orgasm (almost never to almost always), difficulty in achieving orgasm (extremely difficult to not difficult), and satisfaction with the ability to reach orgasm (very dissatisfied to very satisfied). Item scores range from 0 to 5, with higher scores indicating better sexual function, and the orgasm score is weighted by a factor of 0.4, such that the domain score can range from 0 to 6.0.

Time frame: baseline visit

ArmMeasureValue (MEAN)Dispersion
Anorgasmia (Cases)FSFI Orgasm1.9 units on a scaleStandard Deviation 0.7
Normal Orgasmic FunctionFSFI Orgasm5.6 units on a scaleStandard Deviation 0.6
Secondary

FSFI Pain

The pain domain of the Female Sexual Function Index (FSFI) consists of three questions and measures the frequency of discomfort or pain during and following vaginal penetration (almost never to almost always), and the level of discomfort or pain (very low to very high). Item scores range from 0 to 5, with higher scores indicating better sexual function, and the pain score is weighted by a factor of 0.4, such that the domain score can range from 0 to 6.0.

Time frame: baseline visit

ArmMeasureValue (MEAN)Dispersion
Anorgasmia (Cases)FSFI Pain4.9 units on a scaleStandard Deviation 1.1
Normal Orgasmic FunctionFSFI Pain5.5 units on a scaleStandard Deviation 0.6
Secondary

FSFI Satisfaction

The satisfaction domain of the Female Sexual Function Index (FSFI) consists of three questions and measures satisfaction (very dissatisfied to very satisfied) with emotional closeness with partner, sexual relationship with partner, and overall sexual relationship with partner. Item scores range from 0 (or 1) to 5, with higher scores indicating better sexual function, and the satisfaction score is weighted by a factor of 0.4, such that the domain score can range from 0.8 to 6.0.

Time frame: baseline visit

ArmMeasureValue (MEAN)Dispersion
Anorgasmia (Cases)FSFI Satisfaction3.6 units on a scaleStandard Deviation 1.3
Normal Orgasmic FunctionFSFI Satisfaction4.8 units on a scaleStandard Deviation 0.8
Secondary

Total Testosterone

Free & total testosterone, and the calculated free androgen index will be compared; additionally, these levels will be correlated with the questionnaire data and clitoral measurements

Time frame: Between day 1-14 (follicular phase) of menstrual cycle

ArmMeasureValue (MEDIAN)
Anorgasmia (Cases)Total Testosterone26.5 ng/dL
Normal Orgasmic FunctionTotal Testosterone33.0 ng/dL

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026